Heart rate variability predicts anti-tumor necrosis factor therapy response for inflammatory arthritis. [electronic resource]
Producer: 20090203Description: 58-67 p. digitalISSN:- 1872-7484
- Adalimumab
- Adult
- Antibodies, Monoclonal -- therapeutic use
- Antibodies, Monoclonal, Humanized
- Antirheumatic Agents -- therapeutic use
- Arthritis, Psoriatic -- drug therapy
- Arthritis, Rheumatoid -- drug therapy
- Autonomic Nervous System -- drug effects
- Double-Blind Method
- Etanercept
- Female
- Heart Rate -- drug effects
- Humans
- Immunoglobulin G -- therapeutic use
- Male
- Middle Aged
- Predictive Value of Tests
- Receptors, Tumor Necrosis Factor -- therapeutic use
- Severity of Illness Index
- Treatment Outcome
- Tumor Necrosis Factor Inhibitors
- Tumor Necrosis Factors -- immunology
No physical items for this record
Publication Type: Clinical Trial; Journal Article
There are no comments on this title.
Log in to your account to post a comment.